EGFR expression and phosphorylation in HNSCC predict response to EGFR inhibition but cell lines are not representative for the clinical situation

被引：0
|
作者：
von Ahsen, Oliver
Khaznadar, Sami S.
Khan, Martin
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-2786
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2786
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Investigation of the radiosensitization HPV-positive HNSCC cell lines by inhibition of PARP and EGFR
    Rieckmann, T.
    Guester, J. D.
    Weissleder, S.
    Busch, C. -J
    Tribius, S.
    Knecht, R.
    Petersen, C.
    Dikomey, E.
    Kriegs, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 : 29 - 29
  • [2] EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines
    Weiss, G. J.
    Bemis, L. T.
    Nakajima, E.
    Sugita, M.
    Birks, D. K.
    Robinson, W. A.
    Varella-Garcia, M.
    Bunn, P. A., Jr.
    Haney, J.
    Helfrich, B. A.
    Kato, H.
    Hirsch, F. R.
    Franklin, W. A.
    ANNALS OF ONCOLOGY, 2008, 19 (06) : 1053 - 1059
  • [3] The inhibition of PARP but not EGFR results in the radiosensitization of HPV/p16-positive HNSCC cell lines
    Guster, Julian David
    Weissleder, Stephanie Valerie
    Busch, Chia-Jung
    Kriegs, Malte
    Petersen, Cordula
    Knecht, Rainald
    Dikomey, Ekkehard
    Rieckmann, Thorsten
    RADIOTHERAPY AND ONCOLOGY, 2014, 113 (03) : 345 - 351
  • [4] EGFR status and EGFR ligand expression influence the treatment response of head and neck cancer cell lines
    Jedlinski, Adam
    Ansell, Anna
    Johansson, Ann-Charlotte
    Roberg, Karin
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2013, 42 (01) : 26 - 36
  • [5] Expression of EGFR and activated EGFR predict response to (chemo)radiation in cervical cancer
    Noordhuis, Maartje
    Eijsink, Jasper
    ten Hoor, Klaske
    Hollema, H.
    Arts, Henriette
    Pras, Elizabeth
    Willemse, Pax
    de Bock, Geertruida
    Wisman, Bea
    Schuuring, Ed
    van der Zee, Ate
    CANCER RESEARCH, 2009, 69
  • [6] miR-9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCC
    Citron, Francesca
    Segatto, Ilenia
    Musco, Lorena
    Pellarin, Ilenia
    Rampioni Vinciguerra, Gian Luca
    Franchin, Giovanni
    Fanetti, Giuseppe
    Micciche, Francesco
    Giacomarra, Vittorio
    Lupato, Valentina
    Favero, Andrea
    Concina, Isabella
    Srinivasan, Sanjana
    Avanzo, Michele
    Castiglioni, Isabella
    Barzan, Luigi
    Sulfaro, Sandro
    Petrone, Gianluigi
    Viale, Andrea
    Draetta, Giulio F.
    Vecchione, Andrea
    Belletti, Barbara
    Baldassarre, Gustavo
    EMBO MOLECULAR MEDICINE, 2021, 13 (07)
  • [7] EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration
    Riedel, F
    Götte, K
    Li, MF
    Hörmann, K
    Grandis, JR
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2002, 21 (01) : 11 - 16
  • [8] EGFR-amplification correlates with response to combined treatment of fractionated irradiation and EGFR-inhibition in HNSCC tumour xenografts
    Gurtner, K.
    Thurow, C.
    Yaromina, A.
    Eicheler, W.
    Baumann, M.
    Krause, M.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S218 - S218
  • [9] Radiosensitization of HNSCC cells by EGFR inhibition depends on the induction of cell cycle arrests
    Kriegs, Malte
    Kasten-Pisula, Ulla
    Riepen, Britta
    Hoffer, Konstantin
    Struve, Nina
    Myllynen, Laura
    Braig, Friederike
    Binder, Mascha
    Rieckmann, Thorsten
    Grenman, Reidar
    Petersen, Cordula
    Dikomey, Ekkehard
    Rothkamm, Kai
    ONCOTARGET, 2016, 7 (29) : 45122 - 45133
  • [10] Treatment of HNSCC cell lines with the EGFR-specific inhibitor cetuximab (Erbitux®) results in paradox phosphorylation of tyrosine 1173 in the receptor
    Mandic, Robert
    Rodgarkia-Dara, Chantal J.
    Li Zhu
    Folz, Benedikt J.
    Bette, Michael
    Weihe, Eberhard
    Neubauer, Andreas
    Werner, Jochen A.
    FEBS LETTERS, 2006, 580 (20) : 4793 - 4800
12345